brimonidine tartrate, timolol maleate
brimonidine tartrate, timolol maleate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including COMBIGAN. Available dosage form: solution/ drops.
Drug details
- Generic Name
- brimonidine tartrate, timolol maleate
- Brand Names
- COMBIGAN
- Application Number
- NDA021398
- Sponsor
- Allergan, Inc.
- NDC Codes
- 1
- Dosage Forms
- SOLUTION/ DROPS
- Routes
- OPHTHALMIC
- Active Ingredients
- BRIMONIDINE TARTRATE, TIMOLOL MALEATE
Indications and Usage
1 INDICATIONS AND USAGE COMBIGAN ® is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of COMBIGAN dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day. COMBIGAN is a combination of brimonidine tartrate, an alpha-adrenergic receptor agonist, and timolol maleate, a beta-adrenergic receptor inhibitor, indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of COMBIGAN dosed twice a day was slightly less than that seen with the concomitant administration of timolol maleate ophthalmic solution, 0.5% dosed twice a day and brimonidine tartrate ophthalmic solution, 0.2% dosed three times per day. ( 1 )